Switch to: References

Add citations

You must login to add citations.
  1. Professional Oversight of Emergency-Use Interventions and Monitoring Systems: Ethical Guidance From the Singapore Experience of COVID-19.Tamra Lysaght, Gerald Owen Schaefer, Teck Chuan Voo, Hwee Lin Wee & Roy Joseph - 2022 - Journal of Bioethical Inquiry 19 (2):327-339.
    High degrees of uncertainty and a lack of effective therapeutic treatments have characterized the COVID-19 pandemic and the provision of drug products outside research settings has been controversial. International guidelines for providing patients with experimental interventions to treat infectious diseases outside of clinical trials exist but it is unclear if or how they should apply in settings where clinical trials and research are strongly regulated. We propose the Professional Oversight of Emergency-Use Interventions and Monitoring System as an alternative pathway based (...)
    Direct download (3 more)  
    Translate
     
     
    Export citation  
     
    Bookmark   1 citation  
  • No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.Jaime Webb, Lesha Shah & Holly Fernandez Lynch - 2020 - American Journal of Bioethics 20 (9):W1-W4.
    Volume 20, Issue 9, September 2020, Page W1-W4.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations